Link Silicon Valley
The fastest way to connect to the people, companies and capital of Silicon Valley
Free 30 Day Trial Account
Sign Up | Log In
Search
ACQUIRED COMPANY
 
My Lists

Plexxikon  Acquired by Daiichi Sankyo (2011 $ 805,000,000 )

91 Bolivar Drive #A
Berkeley, CA 94710
USA
(510)-647-4000
Website Company Summary Management Team
Management

CEO: Gideon Bollag (6/08)
President/COO/Operations: Paul Lin (5/31/2013)
General Management: Glenn Michelson (8/31/2016) ; Henry Hsu (5/31/2013)
Technology: Chao Zhang (5/31/2013)
Company

Business description: Plexxikon is a leader in the discovery and development of novel, small molecule pharmaceuticals. The company has utilized its proprietary discovery platform to successfully develop a portfolio of competitively differentiated clinical and preclinical stage programs in a number of therapeutic areas and disease indications. Plexxikon’s platform enables the design of highly selective and targeted medicines, supporting the company’s broader strategy to develop personalized medicines.
Partners include: GenentechRoche Sun Microsystems;  Invitrogen;  Phenomix;  Wyeth Pharmaceuticals
Capital

Rounds: 2
Recent Fundings: Mar 2004   Mar 2003
Capital raised: 55.0M
Last Round: 46.0M
Ownership: Acquired by Daiichi Sankyo (2011 $ 805,000,000 )
VCs include: Advanced Technology VenturesAlta PartnersCW GroupNIF VenturesWalden InternationalGIMV;  Kumho Group;  A.M. PappasAndAssociates
Corporate investors: AM Pappas;  Yamanouchi Venture Capital

Last Tweets


 

Last Mentions


Overview
Record updated: Feb 2015
Sector: Biotech
Year Founded: 2000
Headcount: 51-75 as of Nov 2010
Rounds: 2
Recent Fundings: Mar 2004   Mar 2003
Capital Raised: 55.0M
Last Round: 46.0M
Ownership: Acquired by Daiichi Sankyo (2011 $ 805,000,000 )